ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,053.29
      -0.34%
      US Tech 100
      16,993.60
      -0.05%
      Dow Jones
      38,372.27
      -0.34%
      Brent Oil
      86.945
      -0.71%
      Bitcoin
      64,507.40
      -2.89%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Charles River Laboratories International Inc (CRL)

      7. Charles River Laboratories International Inc (CRL) News

      CRL Charles River Laboratories International Inc

      237.73
      -2.40 (-1.00%)
      Last Updated: 12:11:29
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Charles River Laboratories International Inc CRL NYSE Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -2.40 -1.00% 237.73 12:11:29
      Open Price Low Price High Price Close Price Prev Close
      239.28 237.73 244.56 240.13
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/202408:00BWCharles River Laboratories Achieves 100% Renewable..
      4/16/202408:00BWCharles River Laboratories Launches Alternative Methods..
      4/12/202408:00BWCharles River Laboratories Schedules First-Quarter 2024..
      4/11/202408:00BWCharles River and Deciphex Launch Patholytix Foresight, a..
      4/09/202408:00BWCharles River Announces Rare Disease Gene Therapy..
      4/04/202408:00BWCharles River to Perform Plasmid Production for Ship of..
      4/01/202408:00BWCharles River Laboratories Showcases Technology-Driven..
      3/27/202408:00BWCharles River Laboratories Publishes 2023 Corporate..
      3/21/202408:00BWCharles River Announces Extension of Gene Therapy..
      3/14/202408:00BWCharles River and Navega Therapeutics Announce Comprehensive..
      3/12/202408:00BWCharles River Laboratories to Present at Barclays Global..
      3/11/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/08/202414:34EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202412:47EDGAR2Form 144 - Report of proposed sale of securities
      3/01/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/29/202415:14EDGAR2Form 144 - Report of proposed sale of securities
      2/29/202412:42EDGAR2Form 144 - Report of proposed sale of securities
      2/29/202402:00PRNUSWheeler Bio Seals Agreement with Charles River to Offer..
      2/23/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/22/202411:09EDGAR2Form 144 - Report of proposed sale of securities
      2/21/202408:00BWCharles River and Wheeler Bio Complete Agreement to..
      2/20/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/20/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/20/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/20/202408:08BWCharles River Collaborates with Pluristyx, Expanding its..
      2/16/202418:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/15/202416:04EDGAR2Form 144 - Report of proposed sale of securities
      2/15/202411:02EDGAR2Form 144 - Report of proposed sale of securities
      2/14/202407:30EDGAR2Form 8-K - Current report
      2/14/202407:00BWCharles River Laboratories Announces Fourth Quarter and..
      2/05/202420:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/31/202419:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/31/202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/31/202417:34EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
      1/31/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/31/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/31/202417:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/31/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/31/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/31/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/29/202408:00BWCharles River Introduces the First Rapid Animal-Free..
      1/24/202416:34EDGAR2Form 8-K - Current report
      1/24/202416:30BWCharles River Laboratories Adds Reshema Kemps-Polanco to..
      1/23/202416:30BWCharles River Laboratories Schedules Fourth-Quarter 2023..
      1/16/202416:32EDGAR2Form 8-K - Current report
      1/16/202408:00BWCharles River Launches Rep/Cap Plasmids to Streamline..
      1/11/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202408:00BWCharles River Laboratories to Present at J.P. Morgan..

      Your Recent History

      NYSE
      CRL
      Charles River Laboratories
      Delayed Upgrade Clock